Drug Pipeline

4D-150 IVT Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
2
Phase 3
1
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-02 NCT06864988
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular…
Trial sites reduced: 100 -> 95 locations
Active Studies by Phase
Phase 3
2
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07064759 Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization… Neovascular Age-Related Macular Degeneration (nAMD) Recruiting
NCT06864988 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular… Macular Neovascularization Secondary to Age-Related Macular Degeneration Active, Not Recruiting
Phase 1/2
NCT05197270 4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration Neovascular (Wet) Age-Related Macular Degeneration Recruiting
Sponsors Running 4D-150 IVT Trials
Get alerts when 4D-150 IVT trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free